Notification of cessation of securities - NUZ

Sep 15, 2026 at 4:17 AM EDT · Issued by Neurizon Therapeutics Limited via ASX

Filed with ASX · Sep 15, 2026 at 4:17 AM EDT · 4 pages · English

On 6ix: 6ix.com/news/notification-of-cessation-of-securities-nuz-2

Release

Appendix 3H - Notification of cessation of securitiesAppendix 3H - Notification of cessation of securities1 / 4Announcement SummaryEntity nameNEURIZON THERAPEUTICS LIMITEDAnnouncement TypeNew announcementDate of this announcementTuesday September 15, 2026Details of +securities that have ceasedASX...

Neurizon Therapeutics Limited on 6ix

Earlier from Neurizon Therapeutics

Neurizon Announces Partial Redemption of Convertible NotesSep 9
Application for quotation of securities - NUZSep 9
NIH funds Expanded Access Program for NUZ-001 in ALSSep 8
Neurizon Appoints Chief Executive OfficerSep 6
Appendix 4E and 2026 Annual ReportAug 25

Later from Neurizon Therapeutics

Change of Director's Interest NoticeSep 16
Dr Chris Bremer commences as Neurizon CEOSep 30
FDA Type C Feedback, HEALEY trial potentially registrationalOct 5
Updated Investor Presentation and Webinar ReminderOct 6
Change of AGM DateOct 22

All Neurizon Therapeutics news releases

Follow Neurizon Therapeutics into a list and get an email when it puts out news.

Follow Neurizon Therapeutics